The largest database of trusted experimental protocols

Spark10m multiplate reader

Manufactured by Tecan
Sourced in Switzerland

The SPARK10M multiplate reader is a versatile laboratory instrument designed for high-throughput plate-based assays. It features a modular design, allowing for customization to meet specific experimental requirements. The core function of the SPARK10M is to accurately measure and analyze various biological and chemical samples in a multi-well plate format.

Automatically generated - may contain errors

9 protocols using spark10m multiplate reader

1

Antifungal and Antibacterial Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Keratinocytes were cultured in 12-well plates for 48 hrs in EpiLife medium supplemented with either 100 nM calcipotriol or DMSO and without antibiotics. C. albicans or P. aeruginosa (patient isolate) were grown to early log phase in Luria broth (LB). 35,000 colony forming units/well were seeded into a 96-well black microplate (Greiner Bio-One, Kremsmünster, Austria) and 100 µl of conditioned cell culture medium from untreated or treated cells were added. After 3 hrs incubation at 37 °C, 100 µl of resazurin solution (0.5 nM resazurin, Sigma-Aldrich) was added. Plates were incubated at 37 °C overnight in a Spark 10 M multiplate reader (Tecan, Grödig, Austria) which measured fluorescence at Ex 535 nm/Em 590 nm every hour. C. albicans and P. aeruginosa were treated directly with increasing concentrations of LL-37, 100 nM calcipotriol, or DMSO served as controls.
+ Open protocol
+ Expand
2

Cytotoxicity Evaluation of Essential Oils

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cytotoxic effect was studied using the MTT test. Cells were cultivated at a density of 1 × 104 cells/well in a 96-well flat-bottom plate, with three duplicates for each treatment. After 24 h of incubation, cells were treated with varying doses of EO (3.91–1000 µg/mL) for 24 h. To remove extract residues that may interfere with the MTT assay, a wash step with phosphate-buffered saline 1× (PBS) was performed. Cell viability was then measured after 5 h of incubation with 100 μL 1 mg/mL MTT. After removing the solution, 150 μL of DMSO was added to dissolve the crystals. The absorbance of viable cells was measured at λ = 570 nm using a SPARK10M multiplate reader (Tecan, Männedorf, Switzerland). Each plate contained a blank control (medium alone) and a positive control (DMSO 100%) [46 (link)].
+ Open protocol
+ Expand
3

Evaluation of L. alpinum Callus Extract

Check if the same lab product or an alternative is used in the 5 most similar protocols
The effect of L. alpinum callus cultures’ methanolic extract was investigated using the MTT assay. Cells were grown at a density of 1 × 104 cells/well in a 96-well flat-bottom plate, each treatment having 3 replicates. After 24 h incubation, cells were treated with different concentrations of extract (6.25–400 μg/mL) for 48 h. To remove possible extract residues that might interfere with MTT assay, a wash step with Phosphate Buffer Saline 1× (PBS) was performed, then cell viability was determined after incubation for 3 h with 100 μL 1 mg/mL MTT. Afterwards, the solution was removed and 150 μL of DMSO were added to dissolve the crystals. The absorbance corresponding to the viable cells was measured at λ = 570 nm on a SPARK10M multiplate reader (Tecan, Männedorf, Switzerland). A blank control (medium only), and a positive control (DMSO 100%), were included on every plate. The experiment was repeated three times. Statistical analysis was performed using Graphpad Prism (version 8) software (GraphPad Software, San Diego, CA, USA). Cell viabilities were expressed as percentage of control (set as 100%) and represented as mean ± SEM. Data was analyzed by one-way ANOVA followed by Dunnett’s multiple-comparison test.
+ Open protocol
+ Expand
4

Evaluating Anti-Tumor Activity of ADC

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine in vitro anti-tumor activity, various lymphoblastic leukemia cell lines were treated with a 10-fold dilution series of ADC in triplicate in RPMI 1640 media supplemented with 10% heat-inactivated bovine serum (Gibco) for 3 days. Cell viability was measured with a CellTiter-Glo luminescent cell viability assay kit (Promega, G7572) according to the manufacturer’s instructions, and absorbance was determined using a SPARK 10M multiplate reader (Tecan, Switzerland). Untreated cells served as controls. The cell survival rate (%) was calculated using the following formula: (Asample/Acontrol) × 100%. The IC50 was calculated using a non-linear regression analysis using GraphPad Prism 5.0.
+ Open protocol
+ Expand
5

CCR7 Oligomer Functionality in HeLa Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa cells were transiently co-transfected with either pcDNA3 hCCR7-C1 and pcDNA3 hCCR7-C2, or the corresponding CCR7 oligomer single point mutation, at a plasmid ratio of 1:1, which we have previously shown to be best suited based on plasmid concentration titration experiments [7 (link)]. As a negative control, pcDNA3 hCCR7-HA was co-transfected together with pcDNA3 hCCR7-C1. After 40–44 h, cells were washed with PBS g (PBS supplemented with 5 mM glucose), detached with PBS containing 0.5 mM EDTA, and resuspended in PBS-G. Cells were distributed in quadruplicates in a black 96-well half-well plate (Corning, NY, USA), incubated at 37 °C in a Tecan Spark 10M multiplate reader (Tecan, Männdorf, Switzerland), and complemented citrine fluorescence (523–548 nm) was measured after 30 min of incubation.
+ Open protocol
+ Expand
6

Binding Affinity of Zapadcine-1 and Zaptuzumab to Recombinant DR5

Check if the same lab product or an alternative is used in the 5 most similar protocols
High binding 96-well plates were coated with the recombinant DR5 (Sino Biological Inc., Beijing, China) and blocked with 2% BSA/PBS/0.05% Tween-20 solution. Zapadcine-1 and the naked antibody Zaptuzumab at varying concentrations were added respectively in the wells and incubated at 37 °C for 1.0 h. The wells were washed with PBS containing 0.05% Tween-20 (PBST) and incubated with HRP-labeled donkey anti-human IgG-H&L (Abcam, ab102438) at 37 °C. The excess probe was washed from the wells with PBST. TMB (3,3',5,5'-Tetramethylbenzidine) substrate solution (Solarbio, Shanghai, China, PR1200) was added and incubated at room temperature for an appropriate time (usually 5 to 10 min) followed by adding stop solution (1.0 M H2SO4). The optical density at 450 nm was determined on SPARK 10M multiplate reader (TECAN, 1703004862, Switzerland).
+ Open protocol
+ Expand
7

HeLa Cell Bioluminescence Assay for CCR7

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa cells were transiently transfected with pcDNA3 hCCR7-nLuc161, together with pcDNA3 hCCR7-nLuc11 at a 1:1 ratio. Similarly, the corresponding CCR7 oligomer single point mutation pairs were co-transfected. Co-transfection of pcDNA3 hCCR7-nLuc161 and pcDNA3 hCCR7-HA served as a negative control. Transiently transfected cells were washed, transferred in quadruplicates to a 96-well half-well plate (PerkinElmer, Waltham, MA, USA), and incubated with 5 μM coelenterazine H (Biosynth, Staad, Switzerland), at 37 °C in a Tecan Spark 10M multiplate reader. Luminescence (385–440 nm, 350 ms integration time) was measured after 10 min of incubation.
+ Open protocol
+ Expand
8

Cytotoxicity Evaluation of Zapadcine-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cytotoxicity of the Zapadcine-1 was determined by CellTiter-Glo® Luminescent Cell Viability Assay (Promega, G7572) according to the manufacturer's instructions. Briefly, tumor cells and normal cells were seeded into 96-well plates at 2.5×104 cells per well in 100 μL complete medium, then incubated at 37 °C with 5% CO2 overnight. Untreated cells served as control. Zapadcine-1 or Zaptuzumab in 100 μL medium were added in triplicate at various concentrations, respectively, and incubated for 48 h. Absorbance was measured at 450 nm by SPARK 10M Multiplate Reader (TECAN, 1703004862, Switzerland). The cell survival rate (%) was calculated using the following formula: Asample/Acontrol×100%. The 50% inhibitory concentration (IC50) was calculated by SPSS software.
+ Open protocol
+ Expand
9

Luciferase Assay for hTERT Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Luciferase assays were performed as previously described by Gazon et al. [27 (link)]. Briefly, 293T cell line was used to set up the protocol, and then, HuT78 and MyLa cells were transfected with a plasmid DNA mixture containing 100 ng·µL−1 of pGL3‐hTERT‐378‐Luc reporter plasmid [28 (link)], 100 ng·µL−1 of pActin‐βgal, and the indicated amount of pAD/WT1‐IRES‐nAMcyan (gift from Edward McCabe, Addgene [Watertown, MA, USA] #29756). HuT78 and MyLa were electroporated using Gene Pulser XCell Electroporation Systems (Bio‐Rad). Forty‐eight hours post‐transfection, cells were washed with cold PBS and then lysed in 1× passive lysis buffer (Promega). Luciferase and β‐galactosidase assays were both performed in a Spark 10M Multiplate Reader (Tecan, Männedorf, Switzerland) with Genofax A Kit and Genofax B Kit (YELEN, Ballaison, France), and Galacto‐Star Kit (Life Technologies, Grand Island, NY, USA), respectively, as described by the manufacturer. Each experiment was performed in triplicate, and Luciferase activities were normalized for transfection efficiency based on β‐galactosidase. After WT1 overexpression, the levels of hTERT mRNA were also evaluated by qRT‐PCR.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!